These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24187689)

  • 21. Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin.
    Zhao LJ; Wang W; Liu Y; Ren H; Qi ZT
    Antiviral Res; 2012 Nov; 96(2):260-8. PubMed ID: 22985631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity.
    Koutsoudakis G; Romero-Brey I; Berger C; Pérez-Vilaró G; Monteiro Perin P; Vondran FW; Kalesse M; Harmrolfs K; Müller R; Martinez JP; Pietschmann T; Bartenschlager R; Brönstrup M; Meyerhans A; Díez J
    J Hepatol; 2015 Oct; 63(4):813-21. PubMed ID: 26070407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoid derivative Tp80 exhibits anti-hepatitis C virus activity through restoration of GI-GPx expression.
    Nguyen BN; Okuno Y; Ajiro M; Iida K; Denawa M; Yamamoto M; Sakamoto N; Kagechika H; Hagiwara M
    J Med Virol; 2017 Jul; 89(7):1224-1234. PubMed ID: 27922182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct Antiviral Potency of Sofosbuvir Against Hepatitis C and E Viruses.
    Wang W; Hakim MS; Nair VP; de Ruiter PE; Huang F; Sprengers D; Van Der Laan LJ; Peppelenbosch MP; Surjit M; Pan Q
    Gastroenterology; 2016 Dec; 151(6):1251-1253. PubMed ID: 27815000
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibitory Effects of Caffeic Acid, a Coffee-Related Organic Acid, on the Propagation of Hepatitis C Virus.
    Tanida I; Shirasago Y; Suzuki R; Abe R; Wakita T; Hanada K; Fukasawa M
    Jpn J Infect Dis; 2015; 68(4):268-75. PubMed ID: 25672401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of bisindolylmaleimides and indolocarbazoles as inhibitors of HCV replication by tube-capture-RT-PCR.
    Murakami Y; Noguchi K; Yamagoe S; Suzuki T; Wakita T; Fukazawa H
    Antiviral Res; 2009 Aug; 83(2):112-7. PubMed ID: 19549584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humanized-VHH transbodies that inhibit HCV protease and replication.
    Jittavisutthikul S; Thanongsaksrikul J; Thueng-In K; Chulanetra M; Srimanote P; Seesuay W; Malik AA; Chaicumpa W
    Viruses; 2015 Apr; 7(4):2030-56. PubMed ID: 25903832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels.
    Shibata C; Ohno M; Otsuka M; Kishikawa T; Goto K; Muroyama R; Kato N; Yoshikawa T; Takata A; Koike K
    Virology; 2014 Aug; 462-463():42-8. PubMed ID: 25092460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
    Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
    Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lycorine-derived phenanthridine downregulators of host Hsc70 as potential hepatitis C virus inhibitors.
    Chen D; Cai J; Yin J; Jiang J; Jing C; Zhu Y; Cheng J; Di Y; Zhang Y; Cao M; Li S; Peng Z; Hao X
    Future Med Chem; 2015; 7(5):561-70. PubMed ID: 25921398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyruvate dehydrogenase kinase regulates hepatitis C virus replication.
    Jung GS; Jeon JH; Choi YK; Jang SY; Park SY; Kim SW; Byun JK; Kim MK; Lee S; Shin EC; Lee IK; Kang YN; Park KG
    Sci Rep; 2016 Jul; 6():30846. PubMed ID: 27471054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.
    Liu WL; Yang HC; Hsu CS; Wang CC; Wang TS; Kao JH; Chen DS
    Proc Natl Acad Sci U S A; 2016 Dec; 113(51):14799-14804. PubMed ID: 27930338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity.
    Gentzsch J; Hinkelmann B; Kaderali L; Irschik H; Jansen R; Sasse F; Frank R; Pietschmann T
    Antiviral Res; 2011 Feb; 89(2):136-48. PubMed ID: 21167208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of peptides binding to HCV e2 and inhibiting viral infectivity.
    Hong HW; Lee SW; Myung H
    J Microbiol Biotechnol; 2010 Dec; 20(12):1769-71. PubMed ID: 21193836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes].
    Chen H; Ye L; Su JM; Li Y; Zeng JR; Huo WZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):35-8. PubMed ID: 23855126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.
    Nakajima S; Watashi K; Ohashi H; Kamisuki S; Izaguirre-Carbonell J; Kwon AT; Suzuki H; Kataoka M; Tsukuda S; Okada M; Moi ML; Takeuchi T; Arita M; Suzuki R; Aizaki H; Kato T; Suzuki T; Hasegawa H; Takasaki T; Sugawara F; Wakita T
    J Virol; 2016 Oct; 90(20):9058-74. PubMed ID: 27489280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
    Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel small-molecule inhibitor of hepatitis C virus replication acts by suppressing signal transducer and activator of transcription 3.
    Niu Y; Si Y; Li Y; Chi X; Li X; Liu X; Li D; Cheng M; Fan J; Si S; Yang W
    J Antimicrob Chemother; 2015 Jul; 70(7):2013-23. PubMed ID: 25858355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin against hepatitis C virus infection: spicing up antiviral therapies with 'nutraceuticals'?
    Pécheur EI
    Gut; 2014 Jul; 63(7):1035-7. PubMed ID: 24092864
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.